MyAva is a startup, which empowers women to manage chronic health conditions like polycystic ovary syndrome (PCOS), thyroid disorders, insulin resistance and more.
Bonatra is a startup focused on treating and managing chronic diseases, such as diabetes, Hypertension, fatty liver, PCOD, Obesity etc.
“Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health,” Bonatra CEO and co-founder Rahul Kishore Singh stated.
MyAva founder and CEO Evelyn Immanuel said the move further aids the vision of making chronic care management accessible to all women.
Discover the stories of your interest
“We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated,” she added.